Literature DB >> 28696300

Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages.

Wei Jiang1,2, Daojing Li1, Ranran Han1, Chao Zhang1, Wei-Na Jin1,2, Kristofer Wood2, Qiang Liu1,2, Fu-Dong Shi1,2, Junwei Hao3.   

Abstract

The nonneural cholinergic system of immune cells is pivotal for the maintenance of immunological homeostasis. Here we demonstrate the expression of choline acetyltransferase (ChAT) and cholinergic enzymes in murine natural killer (NK) cells. The capacity for acetylcholine synthesis by NK cells increased markedly under inflammatory conditions such as experimental autoimmune encephalomyelitis (EAE), in which ChAT expression escalated along with the maturation of NK cells. ChAT+ and ChAT- NK cells displayed distinctive features in terms of cytotoxicity and chemokine/cytokine production. Transfer of ChAT+ NK cells into the cerebral ventricles of CX3CR1-/- mice reduced brain and spinal cord damage after EAE induction, and decreased the numbers of CNS-infiltrating CCR2+Ly6Chi monocytes. ChAT+ NK cells killed CCR2+Ly6Chi monocytes directly via the disruption of tolerance and inhibited the production of proinflammatory cytokines. Interestingly, ChAT+ NK cells and CCR2+Ly6Chi monocytes formed immune synapses; moreover, the impact of ChAT+ NK cells was mediated by α7-nicotinic acetylcholine receptors. Finally, the NK cell cholinergic system up-regulated in response to autoimmune activation in multiple sclerosis, perhaps reflecting the severity of disease. Therefore, this study extends our understanding of the nonneural cholinergic system and the protective immune effect of acetylcholine-producing NK cells in autoimmune diseases.

Entities:  

Keywords:  CCR2+Ly6Chi monocyte; EAE; NK cell; acetylcholine; immune homeostasis

Mesh:

Substances:

Year:  2017        PMID: 28696300      PMCID: PMC5544318          DOI: 10.1073/pnas.1705491114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  67 in total

1.  Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.

Authors:  Catharina C Gross; Andreas Schulte-Mecklenbeck; Anna Rünzi; Tanja Kuhlmann; Anita Posevitz-Fejfár; Nicholas Schwab; Tilman Schneider-Hohendorf; Sebastian Herich; Kathrin Held; Matea Konjević; Marvin Hartwig; Klaus Dornmair; Reinhard Hohlfeld; Tjalf Ziemssen; Luisa Klotz; Sven G Meuth; Heinz Wiendl
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 2.  T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  J M Fletcher; S J Lalor; C M Sweeney; N Tubridy; K H G Mills
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

3.  IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.

Authors:  Alexander Rölle; Julia Pollmann; Eva-Maria Ewen; Vu Thuy Khanh Le; Anne Halenius; Hartmut Hengel; Adelheid Cerwenka
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

4.  Adhesion to target cells is disrupted by the killer cell inhibitory receptor.

Authors:  D N Burshtyn; J Shin; C Stebbins; E O Long
Journal:  Curr Biol       Date:  2000-06-29       Impact factor: 10.834

Review 5.  Developmental pathways that generate natural-killer-cell diversity in mice and humans.

Authors:  Nicholas D Huntington; Christian A J Vosshenrich; James P Di Santo
Journal:  Nat Rev Immunol       Date:  2007-09       Impact factor: 53.106

6.  Determination of non-neuronal acetylcholine in human peripheral blood mononuclear cells by use of hydrophilic interaction ultra-performance liquid chromatography-tandem mass spectrometry.

Authors:  Chao Zhang; Yiping Xia; Wei Jiang; Chunyang Wang; Bin Han; Junwei Hao
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-04-12       Impact factor: 3.205

7.  Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

Authors:  Ludwig Kappos; Heinz Wiendl; Krzysztof Selmaj; Douglas L Arnold; Eva Havrdova; Alexey Boyko; Michael Kaufman; John Rose; Steven Greenberg; Marianne Sweetser; Katherine Riester; Gilmore O'Neill; Jacob Elkins
Journal:  N Engl J Med       Date:  2015-10-08       Impact factor: 91.245

8.  CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage.

Authors:  Matthew D Hammond; Roslyn A Taylor; Michael T Mullen; Youxi Ai; Hector L Aguila; Matthias Mack; Scott E Kasner; Louise D McCullough; Lauren H Sansing
Journal:  J Neurosci       Date:  2014-03-12       Impact factor: 6.167

Review 9.  Reflex control of immunity.

Authors:  Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

10.  Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues.

Authors:  R T Palframan; S Jung; G Cheng; W Weninger; Y Luo; M Dorf; D R Littman; B J Rollins; H Zweerink; A Rot; U H von Andrian
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

View more
  24 in total

Review 1.  Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.

Authors:  Namrita Halder; Girdhari Lal
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

Review 2.  Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.

Authors:  Luc Van Kaer; Joshua L Postoak; Chuan Wang; Guan Yang; Lan Wu
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

Review 3.  Interaction Between Innate Lymphoid Cells and the Nervous System.

Authors:  Yuanyue Zhang; Rachel Grazda; Qi Yang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  Cholinergic Modulation of the Immune System in Neuroinflammatory Diseases.

Authors:  Marcella Reale; Erica Costantini
Journal:  Diseases       Date:  2021-04-12

5.  Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.

Authors:  Marcella Reale; Erica Costantini; Marta Di Nicola; Chiara D'Angelo; Sara Franchi; Marco D'Aurora; Maria Di Bari; Viviana Orlando; Sabrina Galizia; Serena Ruggieri; Liborio Stuppia; Claudio Gasperini; Ada Maria Tata; Valentina Gatta
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

Review 6.  Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders.

Authors:  Swarup Mitra; Shailesh N Khatri; Malabika Maulik; Abel Bult-Ito; Marvin Schulte
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

Review 7.  Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine.

Authors:  Silvia Capellino; Maren Claus; Carsten Watzl
Journal:  Cell Mol Immunol       Date:  2020-06-05       Impact factor: 11.530

Review 8.  Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease.

Authors:  José L Reyes; Danielle T Vannan; Bertus Eksteen; Imelda Juárez Avelar; Tonathiu Rodríguez; Marisol Ibet González; Alicia Vázquez Mendoza
Journal:  Mediators Inflamm       Date:  2018-08-12       Impact factor: 4.711

Review 9.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

Review 10.  From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment.

Authors:  Stephan Klöß; Susann Dehmel; Armin Braun; Michael J Parnham; Ulrike Köhl; Susanne Schiffmann
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.